Skip to content

042 Biomedical Markers Bipolar & Schizophrenia Dr Walsh-3

biomedical markers, bipolar, schizophrenia, copper, kryptopyrrole

Dopamine elevation matters in schizophrenia, and most current antipsychotic medications aim at lowering activity of this neurotransmitter. Unfortunately, this is the wrong approach for schizophrenics with different brain chemistry.

The post 042 Biomedical Markers Bipolar & Schizophrenia Dr Walsh-3 appeared first on CoreBrain Journal.

About our mission, Dr Charles Parker

Our CBJ hosting objective is critical: upgrade mind and brain data through informed dialogue with neuroscience experts to build more predictable, more comprehensive, more understandable solutions for you and your family. Today's technology drives significantly improved mind-prognosis - beyond traditional psychiatric measures. Inaccurate labels, speculation, and guesswork are out - critical thinking, data, and measurement are in. Let's work together to connect advanced biomedical wisdom with everyday street reality. Start today. Advance informed care. Stay consistent. Measure for accuracy. Subscribe here. Pass it on.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.